ReviewDie Ophthalmologie2026
[Recurrence of herpetic eye disease following cataract surgery: risk factors and prevention].
Review in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herpetic eye disease poses a significant challenge in cataract surgery. On the one hand, patients with a history of herpes infections develop cataracts more rapidly and the surgery itself is associated with a higher rate of intraoperative complications. On the other hand, the risk of herpetic recurrence after cataract surgery is markedly increased (46% for herpes simplex virus and up to 40% for herpes zoster virus). The prognosis is significantly worse in the event of a recurrence, which is why reducing the recurrence rate is of great clinical interest. Preoperatively, attention should be paid to signs of prior herpes infections, such as corneal scars, neovascularization, synechiae and neurotrophic keratopathy. Risk factors for recurrence include the duration of quiescence, the number of previous episodes, a temporal tunnel incision, immunosuppressive therapy, diabetes mellitus and atopy. Prophylactic perioperative antiviral therapy is frequently used; however, randomized data specifically addressing cataract surgery are lacking, so that current recommendations are largely based on indirect evidence and expert consensus.
Indexed as
Identifiers
41805863What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.